Event Director

Senior Software Engineer II

VC Associate

Founded in 2017, Toyota Ventures is a San Francisco Bay Area-based venture capital firm with $800M+ AUM that invests in early-stage startups around the world in deep tech and climate solutions. We are on a mission to discover what’s next for Toyota by helping startups bring groundbreaking technologies and business models to market quickly. We’ve invested in over 100 companies to date, including AM Batteries, Apex Space, Axiom Math, Bipi (acquired), Blackmore (acquired), Efficient Computer, e-Zinc, Intuition Robotics, Joby Aviation (NYSE: Joby), Natura Resources, Pickle Robot, and Stoke Space. Our firm is growing and we are looking for an associate for the Toyota Ventures Frontier Fund(s) to help source and screen innovative companies in areas like AI, advanced materials, automation and robotics, and space tech. Along with a degree in a relevant field and a minimum of 4 years of related work experience, we are seeking someone with a strong understanding of deep tech.

Line Manager, Regulatory Affairs, EU remote

Description Line Manager, Regulatory Affairs, EU remote, Spain, Poland or Germany, This role combines people leadership and operational delivery, actively contributing to the execution of clinical trial regulatory activities. As a Line Manager & Regulatory Affairs Specialist, the employee will be responsible of overseeing Ethics Committee (EC), Regulatory Authority (RA), and other submissions created within or outside of the company to ensure submissions comply with applicable regulations and contractual timelines are met. The Regulatory Affairs Specialist will provide leadership for assigned projects regarding all regulatory activities that lead to startup of clinical trials. As Line Management, the employee will be responsible for resource management and team development of direct reports. This role will be perfect for you if: You do have a strong expertise in clinical regulatory affairs within Europe and globally, including hands-on experience with Health Canada, IRB/IEC submis